STRO vs TMO
Sutro Biopharma (STRO) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
STRO currently screens at market cap $470.8M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the STRO and TMO stock pages for the full models.
Not investment advice.